New Study to Show How Rheumatoid Arthritis Patients Rate
Improvement Change
A new clinical study to determine how people with rheumatoid arthritis (RA) evaluate
improvements in disease symptoms will be carried out by the National Institute of Arthritis and Musculoskeletal and
Skin Diseases (NIAMS), part of the Department of Health and Human Services' National Institutes of Health. The
study will examine how much of an improvement in pain, stiffness, function and other symptoms is needed before
patients consider the change important. The Clinically Important Changes in Rheumatoid Arthritis study will
recruit 300 people 18 years of age or older who have been diagnosed with RA. Researchers are particularly
interested in patients who are currently being treated with prednisone, methotrexate, leflunomide, infliximab or
etanercept. Read
more...
